Microcoat now offering Assay Development and Sample Measurement on MSD® Platform

© 2017 Meso Scale Discovery a division of Meso Scale Diagnostics, LCC. All rights reserved.

Microcoat expands its technological portfolio by Meso Scale Discovery´s Electrochemiluminescence (MSD-ECL) platform. Based on non-radioactive electrochemiluminescent labels for ultra-sensitive detection, MSD yields higher sensitivity and broader dynamic range compared to ELISA technology. Microcoat offers development of assays from the scratch as well as transfer of classical ELISA formats in addition to method comparison, validation and sample measurement.  Customers profit from our year-long experience in custom-fit optimization and manufacturing of antibody conjugates including MSD´s SULFO-Tag®.

MORE NEWS
  • 04Sep

    Press release: HRP2 recombinant panel now available for malaria rapid diagnostic tests

    Read More →
  • 22Jun

    Microcoat now offering Assay Development and Sample Measurement on MSD® Platform

    Read More →
  • 14Jun

    Microcoat announces the launch of WATSON bioanalytical LIMS

    Read More →
  • 31Jan

    Press release: Positive control wells now available for rapid on-site quality assurance of Malaria rapid tests

    Read More →
  • 02Nov

    Meet us at the Munich Biomarker Conference 2016

    Read More →
  • 02Nov

    Meet us at the Pharmalab 2016

    Read More →
  • 18Okt

    Presseinformation: Auf dem Weg zum Teststreifen 2.0

    Read More →
  • 08Apr

    Meet us at the Analytica 2016

    Read More →
  • 01Apr

    Press release: Commercial Launch of reference material for rapid Malaria tests

    Read More →
  • 27Nov

    Meet us at the 5th Annual Outsourcing in Clinical Trials Europe

    Read More →